Ormeloxifene nanotherapy for cervical cancer treatment

BACKGROUND: Cervical cancer (CxCa) ranks as the fourth most prevalent women-related cancer worldwide. Therefore, there is a crucial need to develop newer treatment modalities. Ormeloxifene (ORM) is a non-steroidal, selective estrogen receptor modulator (SERM) that is used as an oral contraceptive in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chauhan, Neeraj, Maher, Diane M, Hafeez, Bilal B, Mandil, Hassan, Singh, Man M, Yallapu, Murali M, Jaggi, Meena, Chauhan, Subhash C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731961/
https://www.ncbi.nlm.nih.gov/pubmed/31564868
http://dx.doi.org/10.2147/IJN.S200944

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731961/
https://www.ncbi.nlm.nih.gov/pubmed/31564868
http://dx.doi.org/10.2147/IJN.S200944

Ejemplares similares